An exploration of medical professionals’ attitudes, perceived knowledge and concerns around medical cannabis in the United Kingdom
Drug Science Journal
Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.
Compliance in the laboratory: Navigating the Controlled Substances Act and Federal Analogue Act in scientific research
3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration
Allaying the fears: MDMA with therapy is a medicine
In defence of the decriminalisation of drug possession in the UK
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
A history of the European Medical Society for Psycholytic Therapy (EPT) 1964–1974
Investigation of the household storage of medicines and disposal practices in Parklands sub-county in Nairobi, Kenya
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Counting and accounting for drug-related deaths at UK music festivals 2017–2023: A commentary
Decrypting the cryptomarkets: Trends over a decade of the Dark Web drug trade
The impact of over the counter and prescription medication misuse on friends and family
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
Racial and religious motives for drug criminalization
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
Perceived barriers to access to hepatitis C for people who inject drugs in Morocco: A qualitative explorative study
Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how
A phenomenological analysis of Fellini's films to understand the effect of LSD therapy on his creativity
Impact of the introduction of medical cannabis in the UK on risk perception and recreational use of cannabis: A longitudinal and cross-sectional analysis
Minorities’ diminished psychedelic returns
Italian psychedelic therapies of the past century: An historical overview
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
Does the co-use of cannabis exacerbate the effect of alcohol on the risk of crashing? A systematic review and meta-analysis
ARC: a framework for access, reciprocity and conduct in psychedelic therapies
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis
A roadmap for psychedelic pharmacy in Canada
Decriminalisation of drug possession in Oregon: Analysis and early lessons
The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study
Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in T21
The United Kingdom's Psychoactive Substances Act 2016. Where are we now?
Examining the gender dimension in the non-medical use of over the counter and prescription only medication
Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness
A comparative study of the harms of nitrous oxide and poppers using the MCDA approach
An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma
How to read a paper on the short-term impairing effects of cannabis: A selective and critical review of the literature
Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident
State naloxone co-prescribing laws show mixed effects on overdose mortality rates
Eating ourselves to death: How food is a drug and what food abuse costs
The Misuse of Drugs Regulations 2001: A case study in poor legislative drafting
A critical review of drug testing policy in the Philippines
Psychedelics as potential catalysts of scientific creativity and insight
Farmability and pharmability: Transforming the drug market to a health-and human rights-centred approach from self-cultivation to safe supply of controlled substances
Regulating the oxides of nitrogen – popping the myths
Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials
How does cannabis affect road crash risk? A systematic review and meta-analyses
Professional Perspectives on Treatment for Substance Use Disorders with Mental Health Problems
Schedule 1 Barriers to Research in the UK: An In-depth Qualitative Analysis
The Cocaine Vape - A concept of a harm reduction device for current users of smokable cocaine forms